-
Reassessment of reimbursement status for medicinal products for hypertension
| 18 December 2006 |
In March 2006, the Danish Medicines Agency contacted a number of scientific societies to clarify certain aspects of the treatment of hypertension in Denmark.
-
Reassessment of reimbursement status of the remaining subgroups of ATC group C
| 18 December 2006 |
The Danish Medicines Agency previously notified companies and a number of scientific societies and patient organisations about which ATC groups and subgroups would be the first to be reassessed, cf. the fact box to the right.
-
Reassessment of ATC-groups C01, C04 and C05
| 18 December 2006 |
At its meeting on 19 September 2006, the Reimbursement Committee had its first discussion of the reimbursement status of the following ATC groups.
-
Reassessment of reimbursement status of ATC-groups C01, C04 and C05
| 18 December 2006 |
At its meetings on 19 September and 7 November 2006, the Reimbursement Committee discussed the reimbursement status of medicinal products in ATC-groups.
-
Reassessment of reimbursement status
| 18 December 2006 |
This summer, the Danish Medicines Agency will begin the periodic reassessment of reimbursement status of medicinal products. Over a 5-year period, the reimbursement status of all medicinal products will be reassessed to ensure that the medicinal products having been granted general reimbursement still meet the required criteria and that medicinal products which have not been granted general reimbursement do not meet the criteria.
-
Reimbursement status of medicinal products aginst hypertension
| 18 December 2006 |
On 6 March 2006, the Danish Medicines Agency wrote a letter to a number of scientific societies to make them clarify certain aspects of the treatment of hypertension in Denmark.
-
Reassessment of ATC group A, Alimentary tract and metabolism
| 18 December 2006 |
At the beginning of 2007, the Danish Medicines Agency is going to begin the reassessment of ATC group A, alimentary tract and metabolism, starting with.
-
Consultation on recommended changes of the reimbursement status of lipid-lowering medicinal products
| 18 December 2006 |
At several meetings, the Reimbursement Committee has discussed the reimbursement status of lipid-lowering medicinal products. In its recommendation of 7 September 2006 for the Danish Medicines Agency, the Committee suggests a change of reimbursement status for these medicinal products.
